Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published
Don Deyo, Executive Chair at Reach Neuro, Inc., shared on LinkedIn about a recent article by Roberto M. de Freitas et al, published in Nature Medicine, adding:
”I am excited to share that the clinical research underlying Reach Neuro‘s breakthrough therapy for post-stroke upper limb impairment has been published in Nature Medicine.
For stroke survivors, the loss of arm and hand function can have a profound impact on independence and quality of life.
This study demonstrates that targeted spinal cord stimulation can significantly improve arm strength, mobility, and dexterity, even years after a stroke.
This publication represents an important milestone in the journey to bring a transformative therapy to the millions of people living with chronic stroke-related disability.
It is a testament to the vision, dedication, and scientific excellence of the researchers, clinicians, engineers, and study participants who made this work possible.
As Executive Chairman of Reach Neuro, I am honored to work alongside such an exceptional team as we advance this technology toward broader clinical application.
My congratulations and gratitude go to Dr. Marco Capogrosso, Dr. Peter Gerszten, Dr. Douglas Weber, Dr. Elvira Pirondini, their collaborators, and the study participants whose commitment made this achievement possible.
Read more about the publication and its significance.”
Title: Spinal cord stimulation for upper limb motor function in people with chronic post-stroke hemiparesis: a feasibility trial
Authors: Roberto M. de Freitas, Shovan Bhatia, Erynn Sorensen, Nikhil Verma, Erick Carranza, Scott Ensel, Luigi Borda, Amy Boos, Jeff Goldsmith, Lee E. Fisher, Daryl P. Fields, Marc P. Powell, Shane Gordon, Jeffrey Balzer, Robert M. Friedlander, George F. Wittenberg, Peter C. Gerszten, John W. Krakauer, Elvira Pirondini, Douglas J. Weber, Marco Capogrosso
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026